GSK Consumer Separation On Track For Summer '22
COVID-19 has not held back GSK's preparations to create the world's largest standalone consumer health business, with CEO Emma Walmsley confirming separation is on track for summer next year.
You may also be interested in...
Not Holding Back: GSK EMEA Head Lanzi On Building The World’s Largest Consumer Health Business During A Pandemic
The new GSK Consumer Healthcare business is well placed to capitalize on self-care trends accelerated by the pandemic, insists the company's EMEA head, Filippo Lanzi, and is already finding ways to bring its flagship brands closer to the new digital-savvy European consumer.
GSK saw investments in e-commerce paying off in 2020 as the firm was able to meet increased demand for consumer health products during the pandemic while many shoppers remained indoors.
With operations in the MENA region already tracking to $700m in revenues for 2020, Hikma is looking to grow the business further after beginning negotiations with GSK to buy certain of the originator’s businesses in Egypt and Tunisia.